Is Lemon Balm Antiviral Against Herpes and More?

Lemon balm (Melissa officinalis) does show genuine antiviral activity against herpes simplex viruses, and the evidence is stronger than for most herbal remedies people ask about. Lab studies consistently find that lemon balm extracts can reduce herpes viral activity by over 90%, and a randomized clinical trial demonstrated real benefits for cold sores in humans. The story extends beyond herpes, too, with emerging research on influenza, HIV, and coronaviruses, though the further you get from herpes, the thinner the human evidence becomes.

What Lab Studies Actually Show Against Herpes

The antiviral case for lemon balm rests on a solid base of cell-culture research. When researchers tested aqueous lemon balm extracts against herpes simplex virus type 1 (the kind that usually causes cold sores), type 2 (typically genital herpes), and an acyclovir-resistant strain of HSV-1, all three were substantially suppressed. At the highest non-toxic concentrations, viral plaque formation dropped by more than 90% for HSV-1 and HSV-2, and more than 85% for the drug-resistant strain.¹ Those numbers are not marginal. In the world of herbal antiviral research, where a lot of plants show weak or inconsistent results, lemon balm stands out.

Other lab work using ethanolic extracts found similarly potent results, with concentrations needed to inhibit 50% of viral activity ranging from just 0.05 to 0.82 micrograms per milliliter, depending on the specific extract and viral strain.² To put that in perspective, those are extremely low concentrations, suggesting that even dilute preparations retain meaningful activity in a lab dish.

An important caveat runs through all of this: these studies were done in cell cultures, not in living humans. Cells in a dish have no skin barrier, no immune system, no bloodstream to dilute the compound. The jump from “kills virus in a petri dish” to “helps a person with a cold sore” is enormous, and plenty of promising compounds fail to make that leap. That said, lemon balm is one of the few herbal antivirals that has also been tested in human trials.

How Lemon Balm Fights the Virus

The key active compound behind lemon balm’s antiviral punch is rosmarinic acid, a polyphenol found throughout the mint family. Researchers have pinpointed the mechanism with unusual clarity for a plant-based remedy. Lemon balm extract and rosmarinic acid block herpes viruses from attaching to host cells in the first place, and they also prevent viral penetration into cells that the virus does manage to reach. In one study, lemon balm extract inhibited viral penetration by 80% for drug-sensitive strains and 96% for drug-resistant ones.³

This mechanism matters for a practical reason. Acyclovir, the standard pharmaceutical treatment for herpes, works by interfering with viral replication once the virus is already inside your cells. Lemon balm works at an earlier stage, intercepting the virus before it can get in. That distinction explains why lemon balm extracts remain effective against acyclovir-resistant herpes strains. The same study found that lemon balm extract interacted directly with free viral particles of two acyclovir-resistant strains at very low inhibitory concentrations, with high selectivity indices, meaning the extract was toxic to the virus at doses far below what would damage healthy cells.³

Computational modeling supports this picture. When researchers used molecular docking simulations to see how rosmarinic acid interacts with herpes virus proteins, they found strong predicted binding, suggesting the compound physically blocks the molecular machinery the virus uses to latch onto cells.⁴ The flip side is that because lemon balm primarily works before the virus enters cells, it appears to have little effect on viruses that are already replicating inside cells.¹ In practical terms, that means timing matters. Applying lemon balm early in an outbreak, when viral particles are still spreading to new cells, would be more useful than applying it once lesions are fully established.

The Human Trial Evidence for Cold Sores

The clinical evidence is thinner than the lab evidence, but what exists is encouraging. A double-blind, placebo-controlled, randomized trial tested a standardized lemon balm cream (containing 1% dried leaf extract at a 70:1 concentration ratio) on people with recurring cold sores. The lemon balm group had significantly lower symptom scores by day two of treatment compared to placebo. Beyond just speeding healing, the cream reduced the spread of infection and quickly improved the typical cold sore symptoms people care most about: itching, tingling, burning, swelling, and redness.⁵

A smaller open-label study with 34 adults who applied lemon balm cream four times daily for five days also found favorable outcomes, with roughly two-thirds of participants having a good or excellent response and most developing either no blisters or just one by day two. Open-label studies carry less weight than blinded trials since participants know what they are getting, but the results line up with the controlled trial’s direction.

What’s missing is large-scale confirmation. We have one solid randomized trial and a few smaller studies, not the kind of deep evidence base that exists for acyclovir. No one has done a head-to-head comparison of lemon balm cream versus prescription antivirals, so we cannot say whether it works as well, better, or worse than standard treatments. For someone looking for a complementary approach, or who prefers to avoid pharmaceuticals for mild cold sores, the evidence supports trying topical lemon balm. For someone with frequent or severe outbreaks, the proven track record of prescription antivirals is still the safer bet.

Activity Against Viruses Beyond Herpes

Researchers have not stopped at herpes. Lemon balm extracts have been tested against a surprisingly wide range of viruses in lab settings, and the results are intriguing if preliminary.

Against avian influenza (H9N2 subtype), lemon balm essential oil inhibited viral replication at multiple stages of the virus’s life cycle, with the strongest effect coming from direct interaction with viral particles before they could infect cells, a pattern consistent with the herpes mechanism.⁶ That study also tested lemon balm oil in combination with oseltamivir (the active compound in Tamiflu) and found the two worked together.

Against HIV-1, aqueous extracts of lemon balm showed high and concentration-dependent antiviral activity in multiple cell types, including immune cells called macrophages and tonsil tissue cultures, with 50% inhibitory concentrations as low as 0.004%.⁷ The proposed mechanism was unusual: the extracts appeared to increase the density of viral particles, essentially destabilizing them. This is strictly a lab finding with no clinical follow-up, and nobody should interpret it as relevant to HIV treatment.

The coronavirus research is more recent. A 2025 study tested lemon balm extracts against SARS-CoV-2 and MERS-CoV in cell culture. The methanol extract showed strong activity, with 50% inhibitory concentrations around 10-11 micrograms per milliliter against both viruses and favorable selectivity indices above 50, meaning the extract was far more toxic to the virus than to the cells.⁸ Molecular docking identified several lemon balm compounds, including hesperidin and luteolin glucoside, that may interfere with the spike protein both viruses use to enter human cells.⁸

A literature review summarizing lemon balm’s antiviral portfolio confirmed activity against HSV, HIV, and SARS-CoV-2 through various mechanisms, from blocking viral binding and replication to inhibiting key viral proteins.⁹ The breadth is genuinely impressive for a single plant. But the pattern is the same across all of these: cell-culture results with no human trials. Nobody has tested drinking lemon balm tea as a flu treatment or using lemon balm extracts against COVID in a clinical setting.

Rosmarinic acid’s antiviral activity may also extend to enteroviruses. Recent research found it inhibited enterovirus A71, a virus that causes hand, foot, and mouth disease in children, by reducing viral protein expression and RNA levels.¹⁰ This underscores that rosmarinic acid’s effects are not limited to one viral family but span enveloped and non-enveloped viruses alike.

How Rosmarinic Acid Moves Through the Body

A compound that destroys viruses in a dish is only useful if it can reach the right tissues in a living person. Rosmarinic acid can enter the body through multiple routes: orally, topically, and even through the lungs via inhalation. When taken by mouth, gut bacteria appear to play a major role in breaking it down into simpler compounds that are more easily absorbed, and it is eventually cleared through the kidneys.¹¹

Topical absorption has been studied in animal models. In rats, rosmarinic acid applied to the skin in an ointment achieved roughly 60% bioavailability, meaning more than half the applied dose made it into the bloodstream. The compound moved through skin about eight times faster from an alcohol-based solution than from water, suggesting that the alcohol in tinctures and herbal extracts may actually help the active compound penetrate skin.¹² That 60% figure comes from rat skin, which is more permeable than human skin, so the real absorption in people is likely lower. Still, for a topical application targeting a cold sore right at the skin surface, systemic absorption matters less than local concentration at the lesion.

The half-life after intravenous dosing in rats was about 1.8 hours, which is fairly short.¹² If this roughly translates to humans, it would mean that frequent reapplication of topical lemon balm, or multiple daily doses of oral preparations, is necessary to maintain effective levels. That aligns with the clinical trial protocol, which had participants apply cream multiple times per day.

Topical Creams, Teas, and New Delivery Systems

Most of the human evidence involves topical creams applied directly to cold sores, and that remains the best-supported use. The standardized cream used in the clinical trial contained a concentrated extract (70 parts plant material to 1 part final extract), which is far more potent than what you would get from rubbing a lemon balm leaf on your lip or drinking a cup of lemon balm tea.

That said, lemon balm tea is a common folk remedy, and the lab evidence does use aqueous (water-based) extracts, which is essentially what tea is. The gap is that nobody has rigorously tested whether the concentration achieved by steeping leaves in hot water is high enough to matter against an active herpes outbreak. It almost certainly is not harmful, but whether it is therapeutic is genuinely unknown.

Researchers are also working on more sophisticated delivery systems. One group developed a nanoemulgel, a gel containing nano-sized droplets of lemon balm and star anise essential oils stabilized by a combination of biosurfactants and synthetic surfactants. The formulation maintained stable droplet size and structural integrity for three months and showed antiviral activity against HSV-1.¹³ These advanced formulations aim to improve how much active compound actually reaches the virus at the site of infection, which has always been a limitation of simple herbal creams.

Why Drug-Resistant Herpes Makes This Research Matter More

Acyclovir resistance in herpes viruses is uncommon in most people, but it is a growing concern in immunocompromised patients, including transplant recipients and people living with HIV. When herpes develops resistance to acyclovir and related drugs, treatment options narrow dramatically. The fact that lemon balm extracts work through a completely different mechanism, blocking viral attachment rather than interfering with replication, means they remain effective against strains that shrug off standard pharmaceuticals.

Lab data consistently confirms this. Lemon balm extracts reduced plaque formation by over 85% even in acyclovir-resistant HSV-1 strains, and the inhibitory concentrations remained extremely low.³ Whether this translates to clinical benefit for immunocompromised patients dealing with resistant herpes is untested, but it represents one of the more compelling reasons to continue developing lemon balm-based antivirals beyond the realm of herbal self-care.

Safety and What We Do Not Know

Lemon balm has a long history of use in European herbal medicine and is generally considered safe at typical doses. Topical application for cold sores appears well tolerated in the available trials, with no serious adverse effects reported. Oral lemon balm preparations are widely sold as calming teas and supplements, and toxicity at normal dietary doses is not a known concern.

There are a few cautions worth noting. Lemon balm has mild sedative properties, so combining it with sedative medications or alcohol could amplify drowsiness. Some sources suggest it may interact with thyroid function, which is relevant if you have a thyroid condition or take thyroid medication. These interactions are not well quantified in clinical studies but have been flagged in systematic reviews of the plant’s pharmacology.

The largest gap in the evidence is the absence of large, well-powered clinical trials. We have strong lab data, a plausible and well-characterized mechanism, favorable pharmacokinetics, and a handful of small human studies pointing in the right direction. What we lack is the kind of evidence that would let a physician confidently prescribe lemon balm cream as a first-line treatment. The research has largely been done in academic pharmacology departments with limited clinical trial budgets, and lemon balm, as a plant that cannot be patented, lacks the financial incentive that drives large-scale pharmaceutical trials. That does not mean the evidence is weak. It means it is incomplete in a specific and predictable way.

Lemon Balm Compared to Other Mint Family Plants

Lemon balm is not the only member of the Lamiaceae (mint) family with antiviral properties. The same study that tested lemon balm against herpes also screened peppermint, prunella, rosemary, sage, and thyme. All six showed high antiviral activity, reducing herpes plaque formation by similar margins.¹ This makes sense given that rosmarinic acid is distributed across the entire family, not unique to lemon balm. Peppermint and sage also showed potent anti-HIV activity in the same lab conditions as lemon balm.⁷

So why does lemon balm get most of the attention? Partly tradition: it has been used specifically for “nervous” complaints and skin ailments in European herbalism for centuries, which made it a natural candidate when researchers went looking for herbal antivirals. Partly concentration: lemon balm tends to have high levels of rosmarinic acid relative to other family members, though the exact amount varies with growing conditions, harvest timing, and extraction method. And partly because it was the one that made it into a clinical trial first, which gave it a head start in the evidence base. If you already grow sage or rosemary and wonder whether they might work similarly against cold sores, the lab evidence suggests they could, but nobody has tested them in a human trial for that purpose.

1
PubMed. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro
2
Forschende Komplementärmedizin / Research in Complementary Medicine. Impact of Ethanolic Lamiaceae Extracts on Herpesvirus Infectivity in Cell Culture
3
PubMed. Attachment and penetration of acyclovir-resistant herpes simplex virus are inhibited by Melissa officinalis extract
4
PubMed Central. (R)-(+)-Rosmarinic Acid as an Inhibitor of Herpes and Dengue Virus Replication: an In Silico Assessment
5
PubMed. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis
6
PubMed Central. Antiviral activity of the oseltamivir and Melissa officinalis L. essential oil against avian influenza A virus (H9N2)
7
PubMed Central. Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density
8
Scientific Reports. Antiviral potential of Melissa officinalis extracts against influenza and emerging coronaviruses
9
PubMed Central. Antiviral Potential of Melissa officinalis L.: A Literature Review
10
PubMed Central. Combined Antiviral and Cytoprotective Action of Rosmarinic Acid Against EV-A71 Infection: A Potential Therapeutic Strategy
11
PubMed. Rosmarinic Acid-Human Pharmacokinetics and Health Benefits
12
PubMed. Percutaneous absorption of rosmarinic acid in the rat
13
İstanbul Journal of Pharmacy. Design and Optimisation of a Biosurfactant-Synthetic Surfactant Hybrid Nanoemulgel Containing Lemon Balm and Star Anise Essential Oils: Stability, Cytotoxicity, and Antiviral Activity Against HSV-1